Mereo BioPharma (MREO) Intangibles (2017 - 2026)
Mereo BioPharma's Intangibles was $256,000 in Q2 2026, down 45.5% from $470,000 a year earlier and down 32.8% from the prior quarter.
Powered by 
Analysis
Mereo BioPharma (MREO) Intangibles (2017 - 2026) Analysis & Trends
At the end of FY2025, Intangibles at Mereo BioPharma came in at $516,000, down 19.8% from FY2024.
- Intangibles shows a five-year compound annual growth rate of -58.5% (FY2020 to FY2025).
- In earlier years, Intangibles was $643,000 in FY2024 (-41.0%), $1.09 million in FY2023 and $33.11 million in FY2021 (-20.8%).
- The Q2 2026 figure marks the lowest quarterly Intangibles in data going back to Q4 2017.
- Compared with a year earlier, Intangibles has declined for seven straight quarters, with an average decline of 35.1% over the last seven quarters.
- The best year-over-year quarter for Intangibles over five years was Q2 2023 (growth of 2.4%); the worst was Q2 2024 (a decline of 97.2%).
- Per Business Quant data, MREO's Intangibles in the three quarters before Q2 2026 was $381,000 (Q1 2026), $516,000 (Q4 2025) and $643,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Mereo BioPharma | 46.31 Mn | -103.60 Mn | - | 256,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 256,000.00 |
| Mar 31, 2026 | 381,000.00 |
| Dec 31, 2025 | 516,000.00 |
| Sep 30, 2025 | 643,000.00 |
| Jun 30, 2025 | 470,000.00 |
| Mar 31, 2025 | 554,000.00 |
| Dec 31, 2024 | 643,000.00 |
| Sep 30, 2024 | 799,000.00 |
| Jun 30, 2024 | 866,000.00 |
| Mar 31, 2024 | 972,000.00 |
| Dec 31, 2023 | 1.09 Mn |
| Jun 30, 2023 | 31.34 Mn |
| Dec 31, 2022 | 29.08 Mn |
| Jun 30, 2022 | 29.26 Mn |
| Dec 31, 2021 | 33.16 Mn |
| Jun 30, 2021 | 30.72 Mn |
| Dec 31, 2020 | 43.14 Mn |
| Jun 30, 2020 | 39.24 Mn |
| Dec 31, 2019 | 58.30 Mn |
| Jun 30, 2019 | 57.25 Mn |
API Access
Mereo BioPharma Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=MREO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "MREO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=MREO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();